BioSpace News Archive

MediWound Ltd. announced positive results from its U.S. Phase 2 clinical study of EscharEx® for the debridement of venous leg ulcers.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, reported its first quarter 2022 operating and financial results.

Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial results for the quarter ended March 31, 2022, and provided operational updates.

Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today reported financial results for the quarter ended March 31, 2022 and provided recent business highlights.

MediPharm Labs Corp. a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release fourth quarter financial results for the three month period ended March 31, 2022 before markets open on Monday, May 16, 2022.

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the first quarter of 2022.

The global humanized mouse model market is estimated to gain a valuation of US$ 188.57 Mn by 2027.

Albany NY, United States: The global hepatic antiviral drugs market is expected to witness strong growth during the forecast period between 2021 and 2031.

The latest professional survey study predicts that the global dental practice management software software market is anticipated to record a significant CAGR of 10.5 % over the study’s forecast period i.e. 2018 to 2026.

Albany NY, United States: The global bioresorbable medical material market is expected to expand at a healthy rate from 2021 to 2031.